[1]Patent:WO2017/214413,2017,A1.Locationinpatent:Paragraph0160-0161
[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2019/308950,2019,A1Locationinpatent:Paragraph0425-0426
334829-66-2 | D,L-SULFORAPHANE N-ACETYL-L-CYSTEINE | AA00C9FP | MFCD09841289
33237-74-0 | APRINDINE HCL | AA00C9LV | MFCD01698392
41340-19-6 | 8-Methyl Etodolac | AA00C9SO | MFCD27967274
344443-16-9 | N-(2-Aminoethyl)-2-(2,6-dichlorophenoxy)propanamide | AA00C9YY | MFCD11614741
319478-14-3 | 5-Bromochroman | AA00CA9V | MFCD08234478
340040-67-7 | (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride | AA00CAP9 | MFCD09954142
41877-40-1 | 2-Methyl-6-oxo-1,6-dihydropyridine-3-carbonitrile | AA00CB0K | MFCD09909816
25116-35-2 | 2-(Naphthalen-1-ylmethylene)-1H-indene-1,3(2H)-dione | AA00CD46 | MFCD00183847
207675-84-1 | 2-(Propan-2-yl)-1,3-thiazole-5-carbaldehyde | AA00CFQI | MFCD14615182
269410-16-4 | 4-Methoxynaphthalen-1-ylboronic acid pinacol ester | AA00CGYF | MFCD22414634